Global Pharmaceutical Packaging

Global Pharmaceutical Packaging

Pharmaceutical packaging is projected to post global demand of $112 billion in 2025, up 6.0% annually from 2020 due to expanding drug production volumes, trends promoting the use of higher value packaging, including increasing drug sophistication and adaptations to new indications, which make packaging requirements more rigorous and costly, and advances in biological and chemical compounds that will broaden the range of pharmaceutical therapies available for widely prevalent diseases and disorders.

This report covers global pharmaceutical packaging demand by Product and Region, along with discussions about trends in materials used to make various products (where applicable). Data are provided in US dollars.

Pharmaceutical packaging products covered in the study include:
Bottles and jars
Blister packaging
Prefillable syringes
Parenteral vials and ampuls
IV Containers
Boxes and cartons
Prefillable inhalers
Pouches
Tubes

Demand is broken out by global regions for the following countries:
North America (US, Canada, Mexico)
Central & South America (Brazil, other countries)
Western Europe (Germany, France, Italy, United Kingdom, Spain, Ireland, Switzerland, other countries)
Eastern Europe (Russia, Poland, Hungary, Czech Republic, other countries)
Asia/Pacific (China, Japan, India, South Korea, other countries)
Africa/Mideast (Turkey, other countries)

Scope of the Report
This report covers the scope, size, and growth of the global pharmaceutical packaging market, including key trends in products, materials, and market segmentation. Historical data are provided for 2010, 2015, and 2020 with forecasts for 2025 and 2030. Year-by-year historical market volatility and short-term annual forecasts are also addressed. Data are provided in US dollars. Also included is an analysis of the key industry players and their market shares.